Mirae Asset Launches Maiden US Life Sciences Fund
31 Jan 2024
US$ 19.00
Mirae Asset Capital Life Science Inc (MACLS), the US-based life sciences-focused venture capital firm of South Korea’s M...
Related Publications
Qiming Venture Partners and the state-affiliated Shanghai Futeng Private Equity Fund Management Co Ltd have co-led ......
Keppel Ltd has raised an aggregate of around US$1.5 bn in new commitments for its two infrastructure funds and a ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.